Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder

Inclusion Criteria

• •Body Mass Index (BMI) ≥ 18.0 to ≤ 40.0 kg/m\^2, inclusive.
• •Participants who currently meet the Diagnostic and Statistical Manual of Mental Disorders treatment (DSM-5-TR) criteria for bipolar I or II disorder without psychotic features based on the Mini International Neuropsychiatric Interview (MINI 7.0.2), currently experiencing a depressive episode of at least 4 weeks and not exceeding 12 months.
• •Normal physical examination findings, clinical laboratory test results, vital signs, and 12-lead ECG results at screening or abnormal results that are judged not clinically significant by the investigator and documented as such in the eCRF
• •Participant with the following psychiatric history:
• •* No history of psychiatric hospitalization (inpatient or intensive outpatient) in the past 3 months prior to screening.
• •* No lifetime history of schizophrenia, other psychotic disorders, dissociative disorders, or neurocognitive disorders.
• •* No history of moderate or severe substance use disorder (except nicotine) in the past 6 months prior to screening.